transaction is an appropriate and beneficial to the Company on a long- term basis, and no disagreement to the Company’s Board of Directors has been raised by the Company’s directors and/or the audit committee

year. Other income for Q2, 2019 are 0.66 million baht which comparable to 0.84 million bath last year with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter2 of the year

(two hundred and forty million Baht) (the “Share Purchase Price”) which shall be paid by Green Ad in cash (the “GSG Shares Acquisition Transaction”); and 2. approved Master & More Co., Ltd. (“Master

that the Company uses to calculate the size of asset acquisition transaction is total of Baht 300 million and assigned the Management to set the closing date when complete the significant conditions for

managing costs appropriately and being more careful with investment plans. The Company expected that this quarter has the deepest contraction in transaction value, and the situation will be better due to

money received from the IPO after deducting the actual expenses 4. Acquisition of all ordinary shares of Modern Pharma Company Limited, "Modern Company", which is a transaction concerning asset

personal expenses and the depreciation because of the expanding capacity of subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing Director

Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and

operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity

& Administrative expenses increased by Baht 23.54 million or 13.02 % due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 3. Finance costs increased by Baht 13.17